Deep Brain Stimulation for Epilepsy in Children

Status: draft · Last updated 2026-11-02 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Overall in children: about 63% respond and 14% become seizure-free. CM, ANT and pulvinar results don't differ significantly in pooled data .
  • Match the target to the network: ANT for focal temporal or frontal epilepsy , CM for generalized epilepsy and LGS , and pulvinar for temporal and posterior networks .
  • ANT targeting:
    • Aim for the anteroventral ANT at the MTT junction, seen on FGATIR .
    • A transventricular trajectory hits the target more reliably (84% vs 58%) .
    • Good placement roughly doubles responder rates .
  • CM targeting:
    • See CM on MP2RAGE .
    • Aim for the anterior-inferolateral parvocellular border, mean MNI about −13, −17, +1 .
    • MER is inconsistent .
  • Pulvinar targeting: aim for the medial pulvinar on an extraventricular trajectory. Consider SEEG sampling first .
  • Safety: major complications in about 4% of children implanted for epilepsy. Watch for mood and memory effects with ANT stimulation .

Landmark papers

  • SANTÉ (Fisher et al., Epilepsia 2010): randomized trial of anterior thalamic stimulation (110 adults). Median seizure reduction was 40.4% with stimulation vs 14.5% without in the blinded phase .
  • ESTEL (Dalic et al., Ann Neurol 2022): randomized trial of centromedian thalamic DBS in 20 young adults with LGS. Electrographic seizures fell by at least 50% in 59% vs none of the controls; diary seizures 50% vs 22%, not significant .

Thalamic DBS is an option for children with drug-resistant epilepsy that can't be resected. The target is chosen by the seizure network:

DBS for epilepsy is off-label in children, and most of the controlled evidence comes from adults.

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:thalamic_targets:97da7a53fee9fad9© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Axial section of the left thalamus (anterior up, midline at left): anterior nucleus with the mammillothalamic tract, mediodorsal, ventral lateral, centromedian and parafascicular nuclei, pulvinar, internal medullary lamina and internal capsule, with the ANT, CM and medial pulvinar targetsANTMDVLVAVPCMPfpulvinarthird ventricle (midline)ANTERIOR ↑ANT targetanteroventral, at theMTT junctionmammillothalamictract (MTT)internal capsuleCM targetanterior-inferolateralborder of CMpulvinar targetmedial pulvinarnot to scale
Schematic axial view of the left thalamus (anterior up, midline at left) showing the three targets: the anteroventral ANT at the mammillothalamic tract (MTT) junction, the anterior-inferolateral border of CM, and the medial pulvinar. The nuclei lie at different depths and are projected onto one plane. Not to scale.

Evidence in children

Choosing a target

Anterior nucleus (ANT)

Targeting the ANT

Centromedian nucleus (CM)

Targeting the CM

Medial pulvinar

Targeting the pulvinar

Related topics

References

  1. Yan H, Toyota E, Anderson M, et al. A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood. J Neurosurg Pediatr 2019;23(3):274–284. doi:10.3171/2018.9.PEDS18417. PMID 30544364. verified
  2. Mhanna A, Ciliberto MA, Ganganna ST, et al. Deep brain stimulation outcomes in pediatric drug-resistant epilepsy: a systematic review and meta-analysis. Seizure 2026;142:281–289. doi:10.1016/j.seizure.2026.09.009. PMID 42767129. verified
  3. Balachandar A, Verhey LH, Mithani K, et al. Surgical complications of deep brain stimulation in children across targets and indications: multicenter analysis of the CHILD-DBS registry. Neurology 2025;105(9):e214201. doi:10.1212/WNL.0000000000214201. PMID 41071966. verified
  4. Fasano A, Eliashiv D, Herman ST, et al. Experience and consensus on stimulation of the anterior nucleus of thalamus for epilepsy. Epilepsia 2021;62(12):2883–2898. doi:10.1111/epi.17094. PMID 34697794. verified
  5. Velasco F, Velasco M, Jiménez F, et al. Predictors in the treatment of difficult-to-control seizures by electrical stimulation of the centromedian thalamic nucleus. Neurosurgery 2000;47(2):295–304. doi:10.1097/00006123-200008000-00007. PMID 10942002. verified
  6. McGinn R, Von Stein EL, Datta A, et al. Ictal involvement of the pulvinar and the anterior nucleus of the thalamus in patients with refractory epilepsy. Neurology 2024;103(11):e210039. doi:10.1212/WNL.0000000000210039. PMID 39531602. verified
  7. Bystrom LL, Levy AS, Brown EC, et al. Thalamic responsive neurostimulation for the treatment of refractory epilepsy: an individual patient data meta-analysis. J Neurosurg Pediatr 2023;32(3):366–375. doi:10.3171/2023.5.PEDS22559. PMID 37347644. verified
  8. Mohanty D, Houck KM, Trandafir C, et al. Responsive neurostimulation of thalamic nuclei for regional and multifocal drug-resistant epilepsy in children and young adults. J Neurosurg Pediatr 2024;34(1):40–48. doi:10.3171/2024.2.PEDS23531. PMID 38608307. verified
  9. Fisher R, Salanova V, Witt T, et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 2010;51(5):899–908. doi:10.1111/j.1528-1167.2010.02536.x. PMID 20331461. verified
  10. Salanova V, Sperling MR, Gross RE, et al. The SANTÉ study at 10 years of follow-up: effectiveness, safety, and sudden unexpected death in epilepsy. Epilepsia 2021;62(6):1306–1317. doi:10.1111/epi.16895. PMID 33830503. verified
  11. Peltola J, Colon AJ, Pimentel J, et al. Deep brain stimulation of the anterior nucleus of the thalamus in drug-resistant epilepsy in the MORE multicenter patient registry. Neurology 2023;100(18):e1852–e1865. doi:10.1212/WNL.0000000000206887. PMID 36927882. verified
  12. Ilyas A, Snyder KM, Thomas TM, et al. Optimal targeting of the anterior nucleus of the thalamus for epilepsy: a meta-analysis. J Neurosurg 2022;137(6):1582–1590. doi:10.3171/2022.2.JNS212550. PMID 35395631. verified
  13. Schaper FLWVJ, Plantinga BR, Colon AJ, et al. Deep brain stimulation in epilepsy: a role for modulation of the mammillothalamic tract in seizure control? Neurosurgery 2020;87(3):602–610. doi:10.1093/neuros/nyaa141. PMID 32421806. verified
  14. Costa-Gertrudes R, Simão D, Franco A, et al. Anterior nucleus of thalamus deep brain stimulation: a clinical-based analysis of the ideal target in drug-resistant epilepsy. Stereotact Funct Neurosurg 2022;100(2):108–120. doi:10.1159/000519917. PMID 34915532. verified
  15. Gross RE, Fisher RS, Sperling MR, et al. Analysis of deep brain stimulation lead targeting in the Stimulation of Anterior Nucleus of the Thalamus for Epilepsy clinical trial. Neurosurgery 2021;89(3):406–412. doi:10.1093/neuros/nyab186. PMID 34161589. verified
  16. Grewal SS, Middlebrooks EH, Kaufmann TJ, et al. Fast gray matter acquisition T1 inversion recovery MRI to delineate the mammillothalamic tract for preoperative direct targeting of the anterior nucleus of the thalamus for deep brain stimulation in epilepsy. Neurosurg Focus 2018;45(2):E6. doi:10.3171/2018.4.FOCUS18147. PMID 30064328. verified
  17. Lehtimäki K, Coenen VA, Gonçalves Ferreira A, et al. The surgical approach to the anterior nucleus of thalamus in patients with refractory epilepsy: experience from the international multicenter registry (MORE). Neurosurgery 2019;84(1):141–150. doi:10.1093/neuros/nyy023. PMID 29554309. verified
  18. Dalic LJ, Warren AEL, Bulluss KJ, et al. DBS of thalamic centromedian nucleus for Lennox-Gastaut syndrome (ESTEL trial). Ann Neurol 2022;91(2):253–267. doi:10.1002/ana.26280. PMID 34877694. verified
  19. Shlobin NA, Hofmann K, Cohen NT, et al. Deep brain stimulation of the centromedian nucleus of the thalamus for Lennox-Gastaut syndrome: a systematic review and individual patient data analysis. Neurosurgery 2023;92(4):703–715. doi:10.1227/neu.0000000000002280. PMID 36700706. verified
  20. Bonda D, Kelly KA, Boop S, et al. Deep brain stimulation of bilateral centromedian thalamic nuclei in pediatric patients with Lennox-Gastaut syndrome: an institutional experience. World Neurosurg 2024;185:e631–e639. doi:10.1016/j.wneu.2024.02.099. PMID 38403017. verified
  21. Mithani K, Niazi F, Suresh H, et al. Deep brain stimulation of the centromedian nucleus for drug-resistant epilepsy in children: quality-of-life and functional outcomes from the CHILD-DBS registry. Epilepsia 2025;66(7):2225–2238. doi:10.1111/epi.18393. PMID 40167366. Full text (PMC) verified
  22. Warren AEL, Dalic LJ, Thevathasan W, et al. Targeting the centromedian thalamic nucleus for deep brain stimulation. J Neurol Neurosurg Psychiatry 2020;91(4):339–349. doi:10.1136/jnnp-2019-322030. PMID 31980515. verified
  23. Warren AEL, Dalic LJ, Bulluss KJ, et al. The optimal target and connectivity for deep brain stimulation in Lennox-Gastaut syndrome. Ann Neurol 2022;92(1):61–74. doi:10.1002/ana.26368. PMID 35429045. Full text (PMC) verified
  24. Filipescu C, Lagarde S, Lambert I, et al. The effect of medial pulvinar stimulation on temporal lobe seizures. Epilepsia 2019;60(4):e25–e30. doi:10.1111/epi.14677. PMID 30767195. verified
  25. Bratu IF, Carron R, Clement A, et al. Medial pulvinar stereoelectroencephalographic biomarkers associated with deep brain stimulation response in focal drug-resistant epilepsy. Epilepsia 2026;67(1):e8–e17. doi:10.1111/epi.70046. PMID 41342095. verified
  26. Wang R, Sacknovitz A, Vazquez S, et al. Bilateral pulvinar responsive neurostimulation for bilateral multifocal posteriorly dominant drug resistant epilepsy. Epilepsia Open 2024;9(6):2263–2273. doi:10.1002/epi4.13068. PMID 39435755. Full text (PMC) verified
  27. Kalamatianos T, Mavrovounis G, Skouras P, et al. Medial pulvinar stimulation in temporal lobe epilepsy: a literature review and a hypothesis based on neuroanatomical findings. Cureus 2023;15(3):e35772. doi:10.7759/cureus.35772. PMID 37025746. verified

Verification (2026-11-02): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. The CM sweet-spot MNI coordinates were taken from the full text of reference 23 (Table 2), the pediatric age range and targeting method from the full text of reference 21, and the pulvinar trajectory from the full text of reference 26, all on PMC. References 4–6, 9–17, 22–25 and 27 are adult or mixed-age; reference 18 enrolled young adults aged 17–37. Reference 27 is a hypothesis-generating review. Indirect AC–PC coordinates for ANT, CM and pulvinar are not given because they could not be verified from accessible sources. The ANT "highly encouraging location" MNI box in reference 14 is described in words rather than numbers. The schematic is an original figure.